Jubilant Pharmova Q3 Results
- BSE: 530019
- NSE: JUBLPHARMA
- ISIN: INE700A01033
- Sector: Biotechnology & Drugs
BSE
996.10
54.20 (5.75%)
54.20 (5.75%)Volume26.96 K
Updated: Mon 17 Feb, 2025 | 13:01:07
NSE
99146.05 (4.87%)
46.05 (4.87%)Volume5.06 L
Updated: Mon 17 Feb, 2025 | 12:46:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹1,821.70 Cr.(8.62%)
- Operating Profit₹177.20 Cr.(43.60%)
- Profit After Tax₹100.90 Cr.(51.05%)
- Operating Margin9.73%(32.20%)
Note: Comparison is on YoY basis
Quarterly - Jubilant Pharmova Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 23 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,821.70 | 1,680.30 | 3.96% | 1,677.10 | 8.62% |
| Selling/ General/ Admin Expenses Total | 560.10 | 531.80 | -0.74% | 581.50 | -3.68% |
| Depreciation/ Amortization | 91.30 | 96.60 | -0.11% | 94.60 | -3.49% |
| Other Operating Expenses Total | 399.80 | 349.40 | 16.29% | 341.70 | 17.00% |
| Total Operating Expense | 1,644.50 | 1,535.10 | 4.85% | 1,553.70 | 5.84% |
| Operating Income | 177.20 | 145.20 | -3.59% | 123.40 | 43.60% |
| Net Income Before Taxes | 130.50 | 98.00 | -9.63% | 101.00 | 29.21% |
| Net Income | 100.90 | 62.50 | -1.85% | 66.80 | 51.05% |
| Diluted Normalized EPS | 7.28 | 3.94 | 2.62% | 4.20 | 73.32% |